Global Veterinary Pain Medication market size is predicted to grow from US$ 5394 million in 2025 to US$ 7886 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

Global Veterinary Pain Medication Market Trends, Growth and Outlook 2025-31

The global Veterinary Pain Medication market size is predicted to grow from US$ 5394 million in 2025 to US$ 7886 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031. United States market for Veterinary Pain Medication is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Veterinary Pain Medication is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Veterinary Pain Medication is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Veterinary Pain Medication players cover Boehringer Ingelheim, Elanco, Zoetis, Baxter, Halyard, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Veterinary Pain Medication Industry Forecast looks at past sales and reviews total world Veterinary Pain Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Pain Medication sales for 2025 through 2031. With Veterinary Pain Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Pain Medication industry. This Insight Report provides a comprehensive analysis of the global Veterinary Pain Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Pain Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Veterinary Pain Medication market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Pain Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Pain Medication. This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Pain Medication market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Injection Medicines &nbsp;&nbsp;&nbsp; Oral Medicines Segmentation by Application: &nbsp;&nbsp;&nbsp; Veterinary Hospitals &nbsp;&nbsp;&nbsp; Veterinary Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Boehringer Ingelheim &nbsp;&nbsp;&nbsp; Elanco &nbsp;&nbsp;&nbsp; Zoetis &nbsp;&nbsp;&nbsp; Baxter &nbsp;&nbsp;&nbsp; Halyard &nbsp;&nbsp;&nbsp; Endo International &nbsp;&nbsp;&nbsp; Forest Laboratories &nbsp;&nbsp;&nbsp; Medtronic &nbsp;&nbsp;&nbsp; Bayer Pharma AG &nbsp;&nbsp;&nbsp; Ceva Sante Animale &nbsp;&nbsp;&nbsp; Ringpu Bio-technology &nbsp;&nbsp;&nbsp; Ruicheng Lvman Biological Pharmaceutical Co., Ltd. &nbsp;&nbsp;&nbsp; Norbrook Laboratories &nbsp;&nbsp;&nbsp; Merck & Co &nbsp;&nbsp;&nbsp; Bostonscientific &nbsp;&nbsp;&nbsp; Lilly &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Harbin Bolai Pharmaceutical Co., Ltd. Key Questions Addressed in this Report What is the 10-year outlook for the global Veterinary Pain Medication market? What factors are driving Veterinary Pain Medication market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Veterinary Pain Medication market opportunities vary by end market size? How does Veterinary Pain Medication break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Veterinary Pain Medication Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Veterinary Pain Medication by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Veterinary Pain Medication by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Veterinary Pain Medication Segment by Type &nbsp;2.2.1 Injection Medicines &nbsp;2.2.2 Oral Medicines &nbsp;2.3 Veterinary Pain Medication Sales by Type &nbsp;2.3.1 Global Veterinary Pain Medication Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Veterinary Pain Medication Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Veterinary Pain Medication Sale Price by Type (2020-2025) &nbsp;2.4 Veterinary Pain Medication Segment by Application &nbsp;2.4.1 Veterinary Hospitals &nbsp;2.4.2 Veterinary Clinics &nbsp;2.4.3 Others &nbsp;2.5 Veterinary Pain Medication Sales by Application &nbsp;2.5.1 Global Veterinary Pain Medication Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Veterinary Pain Medication Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Veterinary Pain Medication Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Veterinary Pain Medication Breakdown Data by Company &nbsp;3.1.1 Global Veterinary Pain Medication Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Veterinary Pain Medication Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Veterinary Pain Medication Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Veterinary Pain Medication Revenue by Company (2020-2025) &nbsp;3.2.2 Global Veterinary Pain Medication Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Veterinary Pain Medication Sale Price by Company &nbsp;3.4 Key Manufacturers Veterinary Pain Medication Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Veterinary Pain Medication Product Location Distribution &nbsp;3.4.2 Players Veterinary Pain Medication Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Veterinary Pain Medication by Geographic Region &nbsp;4.1 World Historic Veterinary Pain Medication Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Veterinary Pain Medication Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Veterinary Pain Medication Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Veterinary Pain Medication Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Veterinary Pain Medication Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Veterinary Pain Medication Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Veterinary Pain Medication Sales Growth &nbsp;4.4 APAC Veterinary Pain Medication Sales Growth &nbsp;4.5 Europe Veterinary Pain Medication Sales Growth &nbsp;4.6 Middle East & Africa Veterinary Pain Medication Sales Growth 5 Americas &nbsp;5.1 Americas Veterinary Pain Medication Sales by Country &nbsp;5.1.1 Americas Veterinary Pain Medication Sales by Country (2020-2025) &nbsp;5.1.2 Americas Veterinary Pain Medication Revenue by Country (2020-2025) &nbsp;5.2 Americas Veterinary Pain Medication Sales by Type (2020-2025) &nbsp;5.3 Americas Veterinary Pain Medication Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Veterinary Pain Medication Sales by Region &nbsp;6.1.1 APAC Veterinary Pain Medication Sales by Region (2020-2025) &nbsp;6.1.2 APAC Veterinary Pain Medication Revenue by Region (2020-2025) &nbsp;6.2 APAC Veterinary Pain Medication Sales by Type (2020-2025) &nbsp;6.3 APAC Veterinary Pain Medication Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Veterinary Pain Medication by Country &nbsp;7.1.1 Europe Veterinary Pain Medication Sales by Country (2020-2025) &nbsp;7.1.2 Europe Veterinary Pain Medication Revenue by Country (2020-2025) &nbsp;7.2 Europe Veterinary Pain Medication Sales by Type (2020-2025) &nbsp;7.3 Europe Veterinary Pain Medication Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Veterinary Pain Medication by Country &nbsp;8.1.1 Middle East & Africa Veterinary Pain Medication Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Veterinary Pain Medication Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Veterinary Pain Medication Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Veterinary Pain Medication Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Veterinary Pain Medication &nbsp;10.3 Manufacturing Process Analysis of Veterinary Pain Medication &nbsp;10.4 Industry Chain Structure of Veterinary Pain Medication 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Veterinary Pain Medication Distributors &nbsp;11.3 Veterinary Pain Medication Customer 12 World Forecast Review for Veterinary Pain Medication by Geographic Region &nbsp;12.1 Global Veterinary Pain Medication Market Size Forecast by Region &nbsp;12.1.1 Global Veterinary Pain Medication Forecast by Region (2026-2031) &nbsp;12.1.2 Global Veterinary Pain Medication Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Veterinary Pain Medication Forecast by Type (2026-2031) &nbsp;12.7 Global Veterinary Pain Medication Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Boehringer Ingelheim &nbsp;13.1.1 Boehringer Ingelheim Company Information &nbsp;13.1.2 Boehringer Ingelheim Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.1.3 Boehringer Ingelheim Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Boehringer Ingelheim Main Business Overview &nbsp;13.1.5 Boehringer Ingelheim Latest Developments &nbsp;13.2 Elanco &nbsp;13.2.1 Elanco Company Information &nbsp;13.2.2 Elanco Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.2.3 Elanco Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Elanco Main Business Overview &nbsp;13.2.5 Elanco Latest Developments &nbsp;13.3 Zoetis &nbsp;13.3.1 Zoetis Company Information &nbsp;13.3.2 Zoetis Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.3.3 Zoetis Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Zoetis Main Business Overview &nbsp;13.3.5 Zoetis Latest Developments &nbsp;13.4 Baxter &nbsp;13.4.1 Baxter Company Information &nbsp;13.4.2 Baxter Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.4.3 Baxter Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Baxter Main Business Overview &nbsp;13.4.5 Baxter Latest Developments &nbsp;13.5 Halyard &nbsp;13.5.1 Halyard Company Information &nbsp;13.5.2 Halyard Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.5.3 Halyard Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Halyard Main Business Overview &nbsp;13.5.5 Halyard Latest Developments &nbsp;13.6 Endo International &nbsp;13.6.1 Endo International Company Information &nbsp;13.6.2 Endo International Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.6.3 Endo International Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Endo International Main Business Overview &nbsp;13.6.5 Endo International Latest Developments &nbsp;13.7 Forest Laboratories &nbsp;13.7.1 Forest Laboratories Company Information &nbsp;13.7.2 Forest Laboratories Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.7.3 Forest Laboratories Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Forest Laboratories Main Business Overview &nbsp;13.7.5 Forest Laboratories Latest Developments &nbsp;13.8 Medtronic &nbsp;13.8.1 Medtronic Company Information &nbsp;13.8.2 Medtronic Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.8.3 Medtronic Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Medtronic Main Business Overview &nbsp;13.8.5 Medtronic Latest Developments &nbsp;13.9 Bayer Pharma AG &nbsp;13.9.1 Bayer Pharma AG Company Information &nbsp;13.9.2 Bayer Pharma AG Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.9.3 Bayer Pharma AG Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Bayer Pharma AG Main Business Overview &nbsp;13.9.5 Bayer Pharma AG Latest Developments &nbsp;13.10 Ceva Sante Animale &nbsp;13.10.1 Ceva Sante Animale Company Information &nbsp;13.10.2 Ceva Sante Animale Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.10.3 Ceva Sante Animale Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Ceva Sante Animale Main Business Overview &nbsp;13.10.5 Ceva Sante Animale Latest Developments &nbsp;13.11 Ringpu Bio-technology &nbsp;13.11.1 Ringpu Bio-technology Company Information &nbsp;13.11.2 Ringpu Bio-technology Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.11.3 Ringpu Bio-technology Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Ringpu Bio-technology Main Business Overview &nbsp;13.11.5 Ringpu Bio-technology Latest Developments &nbsp;13.12 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. &nbsp;13.12.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information &nbsp;13.12.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.12.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Main Business Overview &nbsp;13.12.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Latest Developments &nbsp;13.13 Norbrook Laboratories &nbsp;13.13.1 Norbrook Laboratories Company Information &nbsp;13.13.2 Norbrook Laboratories Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.13.3 Norbrook Laboratories Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Norbrook Laboratories Main Business Overview &nbsp;13.13.5 Norbrook Laboratories Latest Developments &nbsp;13.14 Merck & Co &nbsp;13.14.1 Merck & Co Company Information &nbsp;13.14.2 Merck & Co Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.14.3 Merck & Co Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Merck & Co Main Business Overview &nbsp;13.14.5 Merck & Co Latest Developments &nbsp;13.15 Bostonscientific &nbsp;13.15.1 Bostonscientific Company Information &nbsp;13.15.2 Bostonscientific Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.15.3 Bostonscientific Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Bostonscientific Main Business Overview &nbsp;13.15.5 Bostonscientific Latest Developments &nbsp;13.16 Lilly &nbsp;13.16.1 Lilly Company Information &nbsp;13.16.2 Lilly Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.16.3 Lilly Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Lilly Main Business Overview &nbsp;13.16.5 Lilly Latest Developments &nbsp;13.17 Pfizer &nbsp;13.17.1 Pfizer Company Information &nbsp;13.17.2 Pfizer Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.17.3 Pfizer Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.17.4 Pfizer Main Business Overview &nbsp;13.17.5 Pfizer Latest Developments &nbsp;13.18 Harbin Bolai Pharmaceutical Co., Ltd. &nbsp;13.18.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information &nbsp;13.18.2 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolios and Specifications &nbsp;13.18.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.18.4 Harbin Bolai Pharmaceutical Co., Ltd. Main Business Overview &nbsp;13.18.5 Harbin Bolai Pharmaceutical Co., Ltd. Latest Developments 14 Research Findings and Conclusion

Report	Global Veterinary Pain Medication Market Growth 2025-2031
Selected License	Multi ID: LPI38892

Buyer Information

Order Summary